Ignite Creation Date:
2024-05-06 @ 9:40 AM
Last Modification Date:
2024-10-26 @ 12:18 PM
Study NCT ID:
NCT03046862
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-19
First Post:
2017-02-06
Brief Title:
DurvalumabMEDI4736Tremelimumab in Combination With GemcitabineCisplatin in Chemotherapy-naïve Biliary Tract Cancer
Sponsor:
Organization:
Seoul National University Hospital